Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
- Professor in Molcular Genetics
- ICH Infect, Imm, Infla. & Physio Med
- Institute of Child Health
- Faculty of Pop Health Sciences
DISCLAIMER : Please not that this IRIS record contains numerous inaccuracies which are out of my control. For example, I am a Professor of Molecular Genetics, not Epidemiology and Medical Statistics. My Funding and Students section are also wildly inaccurate but they are not editable by me. I have been advised by UCL IRIS Support that these records are gathered from several Admin sections and I would have to contact each of them to try to make the necessary corrections so this may take some time. So please if you would like to see my correct record please email me (I think the address shown is correct).
Gene therapy offers exciting opportunities for the development oftherapies in virtually all areas of medicine. Recent clinical advances arestarting to realise this potential although there remain many challenges amongst which delivery is a key issue. Much of my research has thereforefocused on this challenging area to develop delivery methods compatible withclinical use. In particular I have developed a family of synthetic gene delivery formulations, or nanoparticles, from conceptual stages through to treatment of disease models in vivo. More recently we have extended our formulations to the delivery of siRNA and other oligonucleotides as well as imaging contrast agents and radiolabels for real-time imaging of delivery in vivo.
I have established a number of collaborations, exploiting the breadth of high quality research groups at UCL, including Departments of Chemistry, Biochemical Engineering, Centre for Respiratory Medicine, and the Centre for Cardiovascular Biology and Medicine. These collaborations have led to highly productive interdisciplinary hypothesis-driven research, involving synthesis ofnovel reagents, studies to establish the fundamental rules and relationshipsconcerning vector structure and function and correction of animal models ofdisease.
Overall the research areas are non-viral vector development and gene therapy for: 1) gene therapy for cardiovascular diseases (bypass grafts), 2) gene therapy for respiratory diseases (cystic fibrosis), 3) gene therapy for cancer (neuroblastoma), 4) gene therapy for the brain, 5) further vector development.
My teaching activity mainly concerns training of research students from MSc to PhD levels.
|1991||PhD||Doctor of Philosophy – Molecular Microbiology||University of Cape Town|
|1986||MSc||Master of Science – Human Genetics||University of the Witwatersrand|
|1981||BSc Hons||Bachelor of Science (Honours) – Genetics||University of Liverpool|